Regulatory T-cells in Psoriasis Patients as Targets for Therapy
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to understand which therapies will suppress effector cells and
promote regulatory T cells and To test whether patients with a better response to therapy and
longer psoriasis-free periods develop a higher numerical ratio of regulatory to effectors
T-cells and/or regulatory cells more able to suppress the effectors.